Skip to content
Urban VIP Choice

The Zimbabwean Government Declines ‘Unbalanced’ American Health Aid Agreement Because of Data Concerns

Medical aid illustration
The proposed US financial assistance was intended for initiatives for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has rejected a significant US healthcare agreement worth $367m (£272m) spanning five years over Washington's demand for confidential biological samples.

This rejection was revealed following a government memo dated December was disclosed, which showed President Emmerson Mnangagwa felt the arrangement was "unbalanced".

A government spokesperson has since stated that the United States was requesting biological samples for research and commercial gain but was unwilling to guarantee the benefits from any future medical innovations.

"We are forced to start the challenging and unfortunate task of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the US had donated more than $1.9bn in health funding to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has urged further dialogue to reach a deal suitable to all parties so the nation's critical HIV programme can continue.

Broader Context

Zimbabwe's decision follows a comparable situation in Kenya, where a high court suspended a similar health funding agreement after concerns were raised about the safety of Kenyans' medical information.

Since resuming office recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.

The agency had overseen assistance for the American government, but Trump claimed its expenditure was "wasteful" and his administration was pursuing government-to-government deals to enhance openness and accountability.

As per statements, Sixteen African countries have so far signed similar agreements, representing over $18.3bn in new funding.

Specifics of the Declined Agreement

The money for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this collaboration might have yielded significant advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy via American-funded programmes," Tremont commented.

However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".

"Zimbabwe was being asked to provide its genetic material and health information indefinitely, with no equivalent assurance of benefiting from any scientific breakthroughs – such as new medicines or tests – that might be developed from that provided information," his statement read.

"In essence, our nation would supply the raw materials for scientific discovery without any certainty that the resulting innovations would be available to our population should a future health crisis arise."

National Interest and Global Health

Mangwana further said that the American exit from the World Health Organization (WHO) and its push of bilateral deals were undermining systems already established via the international health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with future global health emergencies.

"This system is intended to guarantee that when a nation provides its data, the benefits – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to develop them."

These objections regarding the US deal "are not meant as anti-American sentiment," he added.

"We welcome further dialogue with our American counterparts on how future co-operation might be structured in a manner that respects the independence and interests of both nations."

Medical Community Response

A leading public health body said it understood the official position, but recommended that negotiations must proceed since much of the nation's HIV programmes were funded by external financing.

"Where technical issues exist, including those relating to information security or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," it added.

The situation highlights the continuing challenges between accepting vital foreign assistance and protecting national sovereignty in an ever more data-driven world.

TM
By

Thomas Mccall

Lifestyle enthusiast and urban explorer sharing curated insights on premium living.

Urban VIP Choice

Type to search articles.